CELL INTELLIGENCE · 肿瘤细胞治疗研究

病例报告：CD20 双特异性抗体治疗后 CD19 CAR-T 细胞治疗后记忆形成的旁观者 T 细胞反应受损

Case Report: Compromised response of memory-formed bystander T cells after CD19 CAR-T cell therapy following CD20 bispecific antibody therapy.

新诊断弥漫大 B 细胞淋巴瘤的新兴治疗策略

Emerging treatment strategies for newly diagnosed diffuse large B-cell lymphoma.

B 细胞淋巴瘤中 CAR-T 细胞治疗后复发的治疗策略

Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma.

Epcoritamab 在 CAR-T 治疗后复发 CD19-CD5+ 弥漫大 B 细胞淋巴瘤中的有效且安全给药

The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapy.

该病例凸显了 epcoritamab 联合减瘤治疗用于治疗 CAR-T 难治性 CD19 阴性 DLBCL 的潜力。

一例伴视网膜色素变性样眼底表现的儿童急性淋巴细胞白血病

A Case of Childhood Acute Lymphoblastic Leukemia With Retinitis Pigmentosa-like Fundus Findings.

滤泡性淋巴瘤的 CAR-T 细胞与双特异性抗体治疗：近期进展与未来前景

Chimeric antigen receptor T-cell and bispecific antibody therapies for follicular lymphoma: Recent advances and future prospects.

一例 CAR-T 细胞治疗伴持续性 CAR-T 细胞的 DLBCL 早期孤立性中枢神经系统复发的成功病例

A case of successful CAR-T cell therapy for early isolated CNS recurrence of DLBCL with persistent CAR-T cells.